VBIO Valion Bio, Inc. - Common stock
$0.12
Price · Aug 19, 2026
Fundamentals as of Aug 14, 2026
VBIO Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$0.12
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$0 – $1
VBIO Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
—
Free Cash Flow
—
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
VBIO
Peer Median
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
VBIO
Peer Median
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
VBIO
Peer Median
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
VBIO
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
VBIO
Peer Median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
57.9%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| June 30, 2024 | $-0.32 | $-6.12 | 5.8% |
| Sept. 30, 2023 | $-25.16 | $-121.38 | 96.2% |
| June 30, 2023 | $-119.00 | $-138.72 | 19.7% |
| Dec. 31, 2022 | $-289.00 | $-398.82 | 109.8% |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| VBIO | — | — | — | — | — | — |
| AEMD | $3M | -0.2 | — | — | -134.5% | — |
| PFSA | $129.4K | -0.0 | — | — | 47.5% | — |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 10
| Metric | Trend | Q2 2026 |
|---|---|---|
| R&D Expense | $3M | |
| SG&A Expense | $4M | |
| Operating Expenses | $6M | |
| Operating Income | $-6M | |
| Interest Income | $11.0K | |
| Other Non-op | $-633.0K | |
| Net Income | $-7M | |
| EPS (Basic) | $-2.17 | |
| Shares (Basic) | 3,379,997 | |
| EBITDA | $-6M |
Balance Sheet 22
| Metric | Trend | Q2 2026 |
|---|---|---|
| Cash & Equivalents | $2M | |
| Inventory | $750.0K | |
| Prepaid Expense | $524.0K | |
| Current Assets | $3M | |
| PP&E (Net) | $12M | |
| PP&E (Gross) | $13M | |
| Accum. Depreciation | $377.0K | |
| Goodwill | $3M | |
| Intangibles | $2M | |
| Other Non-current Assets | $214.0K | |
| Total Assets | $32M | |
| Accounts Payable | $639.0K | |
| Current Liabilities | $3M | |
| Capital Leases | $9M | |
| Other Non-current Liabilities | $454.0K | |
| Total Liabilities | $21M | |
| Common Stock | $2.0K | |
| Paid-in Capital | $71M | |
| Retained Earnings | $-67M | |
| Stockholders' Equity | $4M | |
| Liabilities + Equity | $32M | |
| Shares Outstanding | 4,151,919 |
Cash Flow 6
| Metric | Trend | Q2 2026 |
|---|---|---|
| Stock-based Comp | $133.0K | |
| Operating Cash Flow | $-5M | |
| CapEx | $57.0K | |
| Investing Cash Flow | $-57.0K | |
| Financing Cash Flow | $231.0K | |
| Net Change in Cash | $-5M |
Profitability 2
| Metric | Trend | Q2 2026 |
|---|---|---|
| ROA | -38.4% | |
| ROE | -179.1% |
Liquidity & Solvency 2
| Metric | Trend | Q2 2026 |
|---|---|---|
| Current Ratio | 1.1 | |
| Quick Ratio | 0.7 |
Valuation (TTM) 7
| Metric | Trend | Q2 2026 |
|---|---|---|
| Revenue TTM | $428.0K | |
| Net Income TTM | $-18M | |
| Market Cap | $2M | |
| P/E | -0.1 | |
| P/S | 5.0 | |
| P/B | 0.5 | |
| Earnings Yield | -1982.7% |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Company insiders 10 insiders · 6 officers · 5 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Jennifer Ernst | Chief Executive Officer | March 12, 2024 A | 1,199,877 | 0 | 0 | $0 |
| Lisa G Wolf | Chief Financial Officer | June 18, 2026 M | 618 | 0 | 0 | $0 |
| Kimberly Ann Bambach | Interim CFO | March 12, 2024 A | 7,500 | 0 | 0 | $0 |
| Veronica Cai | Chief Financial Officer | April 1, 2022 A | — | 0 | 0 | $0 |
| Ryan Sabia | Chief Operating Officer | May 8, 2023 A | — | 0 | 0 | $0 |
| Blake Gurfein | Chief Scientific Officer | March 12, 2024 A | — | 0 | 0 | $0 |
| Christina Rizopoulos Valauri | Director | Aug. 9, 2024 A | — | 0 | 0 | $0 |
| Dean Zikria | Director | Aug. 9, 2024 A | — | 0 | 0 | $0 |
| Karen Drexler | Director | Aug. 9, 2024 A | — | 0 | 0 | $0 |
| Sheryle Bolton | Director | Aug. 9, 2024 A | — | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
Activists & 5%+ owners 1 position
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| 3i, LP, Tumim Stone Capital, LLC, 3i Management LLC, Maier J. Tarlow ×3 filings | Aug. 14, 2026 | 9.90% | Amendment | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.